Holmusk Revenue and Competitors

Location

$31.3M

Total Funding

Estimated Revenue & Valuation

  • Holmusk's estimated annual revenue is currently $15.7M per year.(i)
  • Holmusk's estimated revenue per employee is $140,000
  • Holmusk's total funding is $31.3M.

Employee Data

  • Holmusk has 112 Employees.(i)
  • Holmusk grew their employee count by -13% last year.

Holmusk's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
CEO and FounderReveal Email/Phone
4
COO / CSOReveal Email/Phone
5
Chief Growth OfficerReveal Email/Phone
6
VP Corporate DevelopmentReveal Email/Phone
7
VP RWEReveal Email/Phone
8
VP Medical and Scientific AffairsReveal Email/Phone
9
VP, Real World EvidenceReveal Email/Phone
10
Head EuropeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$76.6M25840%N/AN/A
#2
$84.1M4647%N/AN/A
#3
$1.3M15-6%N/AN/A
#4
$5.2M45N/AN/AN/A
#5
$0.7M9N/AN/AN/A
#6
$5.6M48N/AN/AN/A
#7
$11.9M850%$26.3MN/A
#8
$72.5M414-2%N/AN/A
#9
$33.2M123N/AN/AN/A
#10
$1M12N/AN/AN/A
#11
$33.8M125N/AN/AN/A
#12
$1.5M17N/AN/AN/A
#13
$31.5M20912%$220.7MN/A
#14
$2.3M23N/AN/AN/A
#15
$3.7M32N/AN/AN/A
#16
$0.3M4N/AN/AN/A
#17
$14.4M998%N/AN/A
#18
$1.4M17N/AN/AN/A
#19
$8.4M39N/AN/AN/A
#20
$62.4M210N/AN/AN/A
Add Company

What Is Holmusk?

Holmusk is a digital health and data analytics company focused on solving complex problems in healthcare. We leverage technology and data science to accelerate research and improve outcomes for people with chronic diseases and behavioral health disorders. Based in Singapore, the USA, UK and Malaysia, our proprietary modeling platform leverages scientific research and digital healthcare data to inform predictive algorithms and provide actionable insights for personalized medicine. In addition, we build innovative, scalable and cost-effective digital behavior change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. We are leveraging our strengths in design, analytics and healthcare to bring about meaningful insights and improved outcomes. Our flagship behavior change program is GlycoLeap, a smart coach for Type 2 diabetes. Beautifully designed, simple to use and convenient. (Learn more @ glycoleap.com) Our comprehensive electronic behavioral health records management system is MindLinc, an extensive clinical management tool and repository of data on psychiatric clinical care. Increasing efficiency in care and turning raw mental healthcare data into actionable insights. (Learn more @ mindlinc.com)

keywords:Healthcare, Mobile Health, Big Data Analytics, Digital Health

$31.3M

Total Funding

112

Number of Employees

$15.7M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Holmusk News

2021-08-17 - Holmusk signs agreements with UTHealth and The Harris Center

NEW YORK, Aug. 17, 2021 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest Real-World Evidence (RWE) platform for behavioral health, has signed data license agreements with The University of Texas Health Science Center at Houston (UT ...

2021-04-20 - Holmusk continues ambitious US growth with NYC headquarters and expanded management team

NEW YORK, April 20, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters in New York City and addition of three new members to its mana ...

2021-04-20 - Holmusk continues ambitious US growth with NYC headquarters and expanded management team

NEW YORK, April 20, 2021 /CNW/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters in New York City and addition of three new members to its management ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1124%N/A
#2
$19.2M11310%N/A
#3
$23.7M113-61%N/A
#4
$28.4M1139%N/A
#5
$30.5M113N/AN/A